IA
AIMT

IndexIQ Advisors’s Aimmune Therapeutics AIMT Stock Holding History

IndexIQ Advisors’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-229,016
Closed -$7.89M – 1104
2020
Q3 		$7.89M Buy
+229,016
New +$4.88M 0.32% 56

IndexIQ Advisors's AIMT Position: Q4 2020 in Review

IndexIQ Advisors sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 229,016 shares — an estimated $7.89M sold.

IndexIQ Advisors first reported a position in AIMT in Q3 2020 and held it in 1 quarter. The position peaked at $7.89M in Q3 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

  • IndexIQ Advisors reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
  • IndexIQ Advisors sold 229,016 Aimmune Therapeutics shares in Q4 2020, an estimated $7.89M.
  • IndexIQ Advisors first reported a position in Aimmune Therapeutics in Q3 2020 and held it in 1 quarter.
  • IndexIQ Advisors's Aimmune Therapeutics position peaked at $7.89M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on IndexIQ Advisors's 13F filing for Q4 2020, filed 5 Feb 2021.